APA (7th ed.) Citation

K, M., GW, C., BP, L., Y, S., KT, S., J, S., . . . AL, H. (2024). Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Communications biology, 7(1), 426. https://doi.org/10.1038/s42003-024-06140-6

Chicago Style (17th ed.) Citation

K, Mittal, et al. "Targeting TRIP13 in Favorable Histology Wilms Tumor with Nuclear Export Inhibitors Synergizes with Doxorubicin." Communications Biology 7, no. 1 (2024): 426. https://doi.org/10.1038/s42003-024-06140-6.

MLA (9th ed.) Citation

K, Mittal, et al. "Targeting TRIP13 in Favorable Histology Wilms Tumor with Nuclear Export Inhibitors Synergizes with Doxorubicin." Communications Biology, vol. 7, no. 1, 2024, p. 426, https://doi.org/10.1038/s42003-024-06140-6.